Exane Derivatives Amedisys Inc Transaction History

Exane Derivatives

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$105.12 - $173.85 $525 - $869	-5 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$136.32 - $184.41 $35,306 - $47,762	-259 Reduced 98.11%	5 $0
Q3 2021 Oct 26, 2021	SELL	$149.1 - $270.32 $501,125 - $908,545	-3,361 Reduced 92.72%	264 $39,000
Q2 2021 Jul 28, 2021	BUY	$238.97 - $288.5 $866,266 - $1.05 Million	3,625 New	3,625 $887,000
Q1 2021 Apr 30, 2021	SELL	$236.62 - $314.16 $213,667 - $283,686	-903 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$231.3 - $293.33 $124,670 - $158,104	539 Added 148.08%	903 $264,000
Q3 2020 Oct 06, 2020	BUY	$199.22 - $248.1 $72,516 - $90,308	364 New	364 $86,000

297

28.5M

181K

1.04M

Ticker AMED
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 32,492,000
Market Cap $2.74B
Description
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.